|
08:00 - 08:50 am |
Registration & Coffee Reception |
|
08:50 - 09:15 am |
Opening Remarks
Welcome from HCIA
Prof. Cliff Cramer, Adjunct Professor and Director, Healthcare and Pharmaceutical Management Program, Columbia Business School
|
|
09:15 - 10:00 am |
Keynote Speaker
Marc Tessier-Lavigne, PhD, President, Rockefeller University; Former Chief Scientific Officer, Genentech
"The Future of Translational Medicine and Drug Discovery: Is the Glass Half Empty or Half Full?" |
|
10:15 - 11:30 am |
Concurrent Morning Panels
-
Biopharmaceutical Panel: “Enhancing R&D Productivity and Global Market Access in a Challenging Regulatory and Payor Environment”
-
Venture Capital and Entrepreneurship Panel: “Creating and Managing Innovative Technology-Driven Companies that Address Unmet Medical and System Needs”
-
Medical Technologies Panel: “Innovative Products and Technology Solutions to Improve Health Outcomes and Reduce Costs”
|
|
11:45 am - 12:30 pm |
Keynote Speaker
Sherry A. Glied, Phd, Professor of Health Policy and Management, Columbia University Mailman School of Public Health
Remarks by R. Glenn Hubbard, Dean and Russell L. Carson Professor of Finance and Economics, Columbia Business School
Introduction by Linda Green, Armand G. Erpf Professor of Business
Decision, Risk and Operations Division, Columbia Business School
|
|
12:30 - 1:30 pm |
Conference Lunch |
|
1:45 - 3:00 pm |
Concurrent Afternoon Panels
-
Healthcare Services Panel: “Aligning Stakeholder Interests and Investing in Health Technologies to Improve Patient Care and Lower Costs”
-
Healthcare M&A Panel: “Dealmaking to Access Novel Technologies and Gain Competitive Advantage in a Consolidating Healthcare Sector”
-
Emerging Markets Panel: “Achieving Market Access and Favorable Investment Returns in Developing Healthcare Markets”
|
|
3:15 - 4:15 pm |
Concluding Panel
|
|
4:15 - 5:30 pm |
Networking Reception & Career Fair |